Virax Biolabs Group Limited · NASDAQ:VRAX
Armistice Capital, LLC reported a 9.99% stake in Virax Biolabs Group Limited (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Armistice Capital, LLC reported a 9.99% stake in Virax Biolabs Group Limited, 823,909 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 823,909
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 823,909 |
| Steven Boyd | 9.99% | 823,909 |
Source
Related
- Virax Biolabs Group Limited
- Armistice Capital, LLC
- Virax Biolabs Group Limited shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025